Exenatide vs Semaglutide: Weighing the Pros and Cons
Exenatide vs. Semaglutide: Weighing the Pros and Cons In the dynamic landscape of diabetes management, the emergence of novel therapies such as exenatide and semaglutide has revolutionized glycemic control. Both fall under the class of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), showcasing promising results in